Attached files
file | filename |
---|---|
10-Q - 10-Q - Ocata Therapeutics, Inc. | v166376_10q.htm |
EX-31.1 - EX-31.1 - Ocata Therapeutics, Inc. | v166376_ex31-1.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant
to 18 U.S.C. § 1350, as adopted pursuant to Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that
the Quarterly Report on Form 10-Q for the quarter ended September 30, 2009
of Advanced Cell Technology, Inc. (the “Company”) fully complies with the
requirements of Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 and that the information contained in such Report fairly
presents, in all material respects, the financial condition and results of
operations of the Company.
Date:
November 16, 2009
|
/s/
William M. Caldwell, IV
|
William
M. Caldwell, IV, Chief Executive Officer
(Principal
Executive Officer and Principal Financial Officer)